Romanian Angel Appeal logo

Improving the health of the population in Romania by increasing TB control

Project financed by the Norwegian Grants 2009 - 2014, within the RO 19 - Public Health Initiative.

Grațiela Chiriac is the chief of the pulmonology laboratory in Bacău, one of the 8 laboratories equipped with high-end technology through the project “Improving the Health Status of the Romanian Population in Romania by Increasing Tuberculosis Control”. Dr Chiriac is laboratory doctor and member of the Laboratory Working Group of the National Tuberculosis Prevention, Surveillance and Control Program. We asked her what would be the advantages of the new equipment of the laboratory network.

How does rapid diagnosis help the patient?

The patient’s benefit is considerable, since they can receive the diagnostic early, together with conclusive information about the sensitivity of the infectious strain. Thus, the patient has the opportunity of a treatment initiated early and tailored according to the result of the drug sensitivity test. In these circumstances, the doctors take the right decisions regarding the treatment and the development of chemo-resistance is avoided, as it would make the cases difficult to treat. The liquid media diagnostic method implies inoculation in a liquid media tube, with a standardized technique, and placing it in the equipment which shall monitor the culture. The positive result, which basically confirms the disease, is obtained in 7 – 14 days, and the final result in 42 days. Comparing with the method on solid media, the benefit is obvious: the time to obtain the positive culture is of 7 – 14 days, versus 21 – 60 days; a complete result, culture and drug sensitivity test in 21 days, versus 50 days or even 4 months.

What does this new technology mean for the doctors working in the field?

For the clinicians, the purpose of the activity within the tuberculosis network is to initiate an adequate treatment, as soon as possible, and for the doctors in the laboratories to establish a correct diagnostic, as soon as possible. Correct diagnostic means the isolation of the strain which determines the disease, identifying it as belonging to the Tuberculosis Complex, testing and determining the sensitivity to drugs.

How many patients were diagnosed so far, with this new method, in the laboratory you run?

By the end of June 2015, we had processed through this method 151 culture samples and sensitivity tests. Bacău is among the counties with a tuberculosis incidence above the country average and with an increased number of re-treatments (ed.: relapses, defaults or failures to previous treatments). That is why is necessary to do cultures on liquid media, to ensure a rapid result. In 2008, we considered the idea of the semi-automated MGIT, at that moment being a routine method in Europe. It was a really special moment, although the method is quite time consuming (each tube was manually passed through the fluorescence reader). The automated method we use now, which indicates with sound and visual signals the positive state of one tube, is beyond comparison, even if it took 7 years to get to this point.

Starting with March 2015, 1,000 people with multidrug resistant tuberculosis shall receive complete, continuous and quality treatment. By the end of June, 139 MDR TB patients were enrolled countrywide and receive treatment within the project “Improving the Health Status of the Romanian Population in Romania by Increasing Tuberculosis Control”.

The doctors in the local tuberculosis dispensaries monitor the health status of the patients enrolled in the program, thus helping them not to give up the treatment. We asked Dr Ariadna Petronela Fildan, MDR coordinator in Constanţa county, which are the advantages of this integrated system of patients treatment. Medical sciences PhD and associated professor at the Faculty of Medicine of the Ovidius Univerity, Dr. Fildan has been a pulmonology doctor at the Constanţa Pulmonology Clinical Hospital starting with 2008.

In this project, what does patient-centred approach mean?

The core of the project is the patient, everything – from human to material resources –gravitating around him, aiming to heal the patient and contain the spread of the disease. Once the multidrug-resistant tuberculosis diagnostic confirmed, the fight with the disease begins, fight which is based on well established rules. First of all, the patient is informed by the attending doctor about the new diagnostic methods, the therapeutic options, the duration, advantages and possible complications of the therapy, concurrently underlying the fact that the disease can be defeated if the treatment if followed on a continuous basis, without interruption for the entire duration indicated by the doctor. One shall try to motivate the patient in order to enter the program, bringing as supreme argument the cure and the chance to a normal life. Each patient represents a specific case; they don’t come only with a diagnostic and a disease we must treat, but with an emotional, cultural and social background which we must consider when trying to motivate the patient. We try to answer to all the questions related to the disease and treatment, to provide them as much information as possible, in a clear way, tailored to the personal level of understating.

How important is the medical care accompanied by psychological care, how does this actually take place in hospitals? Which are the advantages and what is the difference between the new possibilities and what was done before?

Evidently, the psychological support is very important; a trained person can find the methods adequate to each patient to motivate them not to give up the treatment. In fact, the most important aspects in the success of a treatment are, first and foremost, the compliance and ensuring continuity. Psychological counselling at the initiation of the treatment but also during the entire course, when complications – some quite difficult to deal with and to control – might appear, is a major contributor to the therapeutic success. Unfortunately, not all the hospitals have trained staff and in this situation is our hospital in Constanţa as well. To bridge the gap, the discussions with the patient take place with the participation of the attending doctor, the chief of department or the chief of dispensary (according to the case, if the patient is hospitalized or in ambulatory), the medical director and the program coordinator. The advantages we have at this moment are considerable, starting with the fact that we can have an MDR TB diagnostic in a few hours, compared to a few months, through access to the newest molecular diagnostic methods, continuing with access to modern therapy, ensuring continuity, the treatment regimens being those established by the MDR commission, according to the international guidelines.

Social support: what is the role of the social vouchers?

The role of these vouchers is a motivational one. It has been observed that providing monthly “bonuses” – if the patient came to the doctor and was given the treatment in the presence of the doctor or nurse – increases the treatment compliance rate. As it is very well known, many of the patients face serious material difficulties and thus any help is welcome.

What feedback do you have from your patients, regarding this approach?

The patients are satisfied because they have the continuous treatment ensured, have an additional chance, by being included in this program, and understand the importance of the correct administration, without interruption, of the medication, because this is the only way they can be cured.

How many patients are enrolled in this program in Constanța?

Currently there are five patients enrolled for complete regimens and eleven patients enrolled for social support in order to increase their compliance to treatment. We hope as many as possible will be accepted.

What is the situation in the county regarding tuberculosis?

In Constanţa County, the tuberculosis incidence decreased constantly in the past 10 years, from the 3rd place at national level to the 12th place. Last year 634 cases of tuberculosis, new cases and relapses were notified, representing an incidence of 87.6 versus 89.9 per 100,000 inhabitants, in 2013. 38 cases were notified in children. What we noticed for the first half of this year is the high number of severe cases registered in our hospital, extended, milliary forms, meningo-encephalitis. Until now we had 13 deaths due to tuberculosis, which probably can be explained by the long latent period between the occurrence of the symptoms and the visit to the doctor.

Marian Istrate is 41 years old, lives in Bucharest and in April 2015 was hospitalized at the “Marius Nasta” Pulmonology Institute in Bucharest, with the diagnostic of multidrug resistant tuberculosis. He left at home his wife and their 19 years old daughter who just had the bachelor degree exam, worried that there are chances he would have given them the Koch bacillus. In an interview conducted in his room from “Marius Nasta” Institute, Istrate told us how he ended up being diagnosed with tuberculosis and what his hopes for the future are.

“I don’t know, I have several problems, and the most important is Crohn’s disease, which I have been fighting for 10 years now. (ed.: Chron’s is a chronic inflammatory disease, localized in the digestive tract wall). Because of this disease I had a stroke, trombophlebitis, there were several things linked to each other. Then some biologic treatments for the Chron’s disease appeared and the doctors proposed to follow them.

Thus, as I ended up doing all sorts of investigations in hospitals, in 2007 they discovered I had pleurisy. Then, in 2013, they noticed a spot on the right superior lobe of the lungs and the doctors told me I had TB. I followed 1st line treatment, except that the spot didn’t become larger, but it didn’t shrink also. And I thought to myself: if I cut my finger, then it swallows, it gets infected or it heals. But in my case the spot remained there, even after the treatment.

I took the TB treatment for 6 months, plus the biologic treatment for my disease and it went ok. I used to go to Fundeni, but I wasn’t hospitalized, I was going twice a month and get a dose every two weeks. And at the end of last year they changed my treatment with an intravenous one. I had only two doses and during New Years Eve, in December 2014, I had fever, chills. It passed after 2-3 days or so and, after about half a month, I thought I should go to the hospital to see what’s going on.

I had an X-ray and they told me I had a tumour. And I had to have a bronchoscopy done afterwards and it didn’t turn out to be TB, cancer, or any tumour, but some sort of pneumonia. I was put for 20 days on Cefort iv treatment, and in the sputum sample didn’t appear anything. In March, they put me on 1st line treatment, but the spot remained. By end of April, a lady doctor calls me, telling they did the drug sensitivity test and that it turned out multidrug resistant tuberculosis. “Wouldn’t I better go and buy a coffin?” I said to myself.

On 29 April I was hospitalized. It is suspected that I took it (ed. the bacillus) from somewhere in a hospital. At least 2 month I’ll stay here at “Nasta”. To my surprise, I coped with the treatment, although I was afraid I couldn’t do it. As a patient here, one begins to get used with the idea of the disease, of tuberculosis, of severe diagnostic. I still have bad nausea, sometimes I even feel sick to drink water. It has to pass, you end up saying to yourself.”

 

Marian Istrate is only one of the thousands of patients with multidrug-resistant tuberculosis in Romania, to whom the lack of high performance methods of rapid and correct diagnosis of the disease made loose precious time. Two years – the time when Marian was incorrectly treated for sensitive tuberculosis – represent a period when multidrug resistant tuberculosis would have been cured, with the proper and timely initiated medication.

Access to rapid diagnostic, thanks to the high-end equipment procured through the project “Improving the Health Status of the Romanian Population in Romania by Increasing Tuberculosis Control” allows receiving the diagnostic in very short time (from few hours up to few days) and beginning the correct treatment, offering the patients like Marian Istrate the chance to be cured and have a normal life.

*Marian Istrate is a fictional name; we decided to change it at the patient’s request.

Courses for healthcare professionals, to increase skills in TB control

During June 2015, five courses for health professionals in the field of pneumonology were held in Ploiesti (05.06 – 06.07.2015 for doctors in Ploiesti), Constanta (05.06 – 06.07.2015 for doctors in Constanta), Timisoara (12.06 – 14.06.2015 for doctors from Timis county and in Caransebes), Pitesti (19.06 – 21.06.2015 for doctors Dambovita and Arges counties), Cluj-Napoca (26.06 – 06.28.2015, for doctors from Cluj and Bistrita in Nasaud).

165 health professionals were trained in the field of respiratory medicine until now, within the project, through 7 training sessions. 117 of the professionals were trained in June.

Also in June it was completed the process of collecting the documents necessary for the conclusion of contracts for trainers courses, for 600 doctors and nurses working in PNPSCT network.

TB patients testing across the country, for rapid MDR TB diagnose

The data corresponding to the testing activity in the 8 laboratories equipped by the project, shows a total of 1,722 patients tested during June 2015, with the LPA and MGIT equipment. 63 patiens were found with resistant TB, including 22 with MDR TB.

Since March to June 2015, 3937 patients were screened within the project; 282 patients were found to have resistant TB, of which 106 have MDR TB.

Complete, continuous and quality treatment for patients with MDR TB

In June 2015, 38 more patients were enrolled in order to receive treatment for resistant tuberculosis, in addition to the 101 included up to May 31, in total being enrolled 139 patients with MDR TB.

By the end of June, the MDR TB project experts completed analysis of databases of all 41 counties and 6 districts of Bucharest. Of all cases analyzed, 422 were considered eligible and proposed to be communicated to MDR TB coordinators whose role is to ovesee the filing and forwarding of the relevant cases towards the two MDR TB committees, for enrollment in treatment.

The project’s team together with the MDR TB experts continued tu provide the MDR coordinators and physicians, information and clarifications about the  of cases forwarded to the MDR TB commission and also useful information about medication orders and stock management of anti-TB drugs.

During the current month , the last batch of drugs was received , part of the initial order (for the first 200 patients). The project team continued the correspondence with GDF and IDA regarding the next medication delivery, and the expiration deadlines for the other drugs that still need to be delivered.

DOT and incentives for MDR TB outpatients, in order to increase treatment adherence

In June, the regional coordinators sent to the MDR TB coordinators the latest database of patients diagnosed with resistant TB (RR, MDR-TB, XDR-TB) or sensitive TB and with a high risk of mortality, failure or treatment abandonment. The data were analyzed by expert physicians who made recommendations for enrollment.

Of the 1706 patients considered eligible to be enrolled in the project, 401 records submitted signed consent by the end of the month.

For patients eligible to receive social support for adherence to TB treatment administered under medical observation, throughout May, the project team has centralized the following information:

– 246 unique patients received social support so far in the project, status confirmed by treating physicians and comunicated by the MDR TB coordinators.

– Cumulatively, in June and May, tickets have been distributed to a total of 405 patients (166 in May and 239 in June), of whom 161 patients received vouchers for maintaining adherence in both months.

Also in June:

– For the process of updating the national database to be in line with TB WHO recommendations, the project’s team asked for technical assistance from the ECDC (the appointment of an expert in epidemiological surveillance for a mission of at least 3 days). According to the ECDC Director’s answer, the appointed expert is Vahur Hollo and the mission will take place in the next period.

– Preparations were made to finalise the signing of the contract with the World Health Organization and an official address was sent to ANRMAP to ask the opinion of the Agency on the OUG 34/2006 except for direct contracting of the World Health Organization.

– The project’s presentation brochure was printed, both in Romanian and English.

Expenditures for the period 1 to 30 June 2015 are shown in the table below

No

BUDGET LINE

Value of expenses

in M11

1

Human Resources

296,663.22

2

Travel Costs for the staff and volunteers

5,137.03

3

Consumables

0.00

4

Investigation Costs (under the upper limit established for each project)

0.00

5

Other costs related to the services supply to the beneficiaries

165,133.00

6

Project Communication and Promotion

0.00

7

Bilateral activities

0.00

8

Other subcontracted activities

51,899.12

9

Indirect Costs

18,382.63

10

Unexpected Costs

0.00

Total

537,215.00

 

 

All counties were assigned for sending samples to the labs equiped through the project, for rapid diagnosis of TB MDR / XDR

In May 2015, the TB patients’s testing through rapid MDR / XDR TB diagnosis techniques continued in the PNPSCT’s network laboratories in Bucharest, Cluj, Bacau, Brasov, Constanta, Craiova, Sibiu and Timisoara – the labs were equipped with appropriate equipment and supplies. All counties were assigned for sending samples to these laboratories, thereby ensuring patients across the country access to rapid diagnosis. By the end of May 2015, 2,186 patients had been screened (of which 1341 patients only in May); 195 patients were found to have TB resistance, of which 78 have MDR TB.

The number of patients enrolled in treatment in the project increases – 101 people, up to May 31, 2015

33 more patients with MDR TB were enrolled in the project in May, in addition to the 68 enrolled until the end of April to receive complete, continuous,  quality treatment. The total number of MDR TB patients enrolled for getting medication is 101.

The inclusion of patients in treatment is based on the MDR TB Commission’s decision as a result of eligible patient dossier and the patient’s signed consent sheet submission to the Commission. By the end of May the information was collected in Bucharest and in all counties. The MDR TB experts continued the analysis of the project database and identified 600 patients with resistant tuberculosis that could receive treatment through the project. In the next period, this information will be communicated to the MDR coordinators who will supervise the process of forwarding the patient files to the  two MDR TB committees, in order to enroll them in treatment.

During May, the dossier for authorization of special needs for medication has been deposited at the National Medicines Agency,   and the correspondence with GDF and IDA, concerning the next disbursements of drug deliveries in the country, and  the expiration deadlines for the  drugs that will be delivered, was continued.

The process of data centralizing and eligibility analysis for social support was completed and the incetivising program was initiated in order to increase the adherence to treatment

After centralizing the databases  that the MDR coordinators received from all over the country until the end of May, regarding patients with resistant tuberculosis or sensitive TB patients with high risk of mortality, treatment failure or abandonment, , 1746 patients were considered eligible to be enrolled in the project. According to the methodology, once considered eligible to benefit from social support, the patients must submit signed consent sheets. 363 patients from 1746 submitted their signed consent sheets by the end of May.

For patients eligible to receive social support for anti-TB treatment adherence administered according to medical recommendations throughout April, the project team has centralized the following information:

– 160 patients were eligible to receive social vouchers – meaning 160 patients who completed and signed consent records up to April 10, 2015 (those who signed after this date will receive the tickets the following month).

– The 160 patients received social support in May in order to keep treatment adherence, status confirmed by the patient’s treating physicians and communicated by the MDR TB coordinators –through  completing and signing the monthly centralizers which have been forwarded to the RAA Foundation’s regional coordinators during the month.

On 9th and 10th of May, the project team organized, in Bucharest, the first meeting of the national MDR TB coordinators. The event was attended by 35 MDR coordinators and the topics were presented by lecturers from the « Marius Nasta » Institute and Romanian Angel Appeal Foundation.

During the meeting, the mobile phones and HEPA masks for the voluntary activity performed by MDR coordinators in order to increase patient adherence to treatment, were also distributed.

For the MDR coordinators who could not be present at the first meeting, monitoring and evaluation visits were organized, in order to inform and train them. By the end of May, the RAA coordinators visited Neamt, Cluj, Salaj, Hunedoara, Satu Mare and the Ambulatory of Pneumology of District 1, Bucharest.

Providing the laboratories in the country with MDR rapid diagnosis and IT equipment  

During this period, the supply the laboratories with GeneXpert equipment (8 devices) and Versatrek equipment (3 devices) continued . For GeneXpert equipment procurement the contract was signed with the company declared the winner of the selection procedure, as for the Versatrek equipment and supplies, the documents necessary for the selection process were finalized and the procedure will be officially launched on specialized sites after approval  of the unit investment list for 2015, by the Ministry of Health.

Other TB laboratories in the country will be equipped with protective hoods (44 labs), LED microscopes (10 labs), IT equipment and vehicles.

For the purchase of 44 protective hoods and 10 LED microscopes the technical specifications were developed in order to launch the selection procedure of the supplying company and the supplier selection procedure will be launched when the necessary funds will be available.

For the purchase of IT equipment and vehicles, the technical specifications development was completed and also the lists of TB units that need to be equipped through project. The procedure for selecting suppliers will be released upon receipt and approval, by the Ministry of Health, of the list of investment funds.

Also in May:

– Two courses for health professionals in the field of pulmonology were held in Timisoara (15.05 – 17.05.2015) and in Sibiu (28.05 – 30.05.2015), in order to increase the  containment of TB in Romania

– A work meeting of  the representatives of the Project Promoter, the RAA Fondation and the World Health Organization was held for arranging the procedure of contracting the WHO  and the joint missions financed by the Global Fund and Norwegian Fund.

– The first training course on health communication was held, meant to create new trainers

– The projects’s presentation brochure’s layout was finalized.

Expenditures for the period 1 to 31 May 2015 are shown in the table below:

No

BUDGET LINE

Value of expenses

in M10

1

Human Resources

265,737.00

2

Travel Costs for the staff and volunteers

1,397.64

3

Consumables

2,284,665.88

4

Investigation Costs (under the upper limit established for each project)

0.00

5

Other costs related to the services supply to the beneficiaries

15,864.94

6

Project Communication and Promotion

0.00

7

Bilateral activities

0.00

8

Other subcontracted activities

98,204.09

9

Indirect Costs

4,151.46

10

Unexpected Costs

0.00

Total

2,670,021.01

 

 

Diagnosis is now possible, within a few hours along with complete, quality treatment, through a project financed by Norway Grants

During April, eight laboratories in Romania began the testing for rapid diagnosis of multidrug resistand and extensively resistant tuberculosis (MDR/XDR TB). There are two laboratories in Bucharest and Cluj and six TB laboratories in Bacau, Brasov, Constanta, Craiova, Sibiu and Timisoara. The laboratories are part of the National Programme for Prevention, Surveillance and Control of Tuberculosis (PNPSCT) and receive samples for testing from all over the country.

The eight laboratories perform rapid diagnosis of MDR/XDR TB, after being equipped with MGIT and LPA advanced equipment and test kits, through the project “Improving the health status of the population in Romania, by increasing TB control”, co-financed the Norway Grants 2009 – 2014. The project, in which Romanian Angel Appeal is a partner, is developed through the Public Health Initiatives Program, operated by the Ministry of Health.

After just a few weeks since the equipped laboratories started the work on modern equipment, 707 people with TB have benefited from the rapid testing. It is about genetic testing, in 24 or 48 hours, of the presence of the TB bacilli in sputum and its resistance to the most powerful anti-TB drugs – Isoniazid and Rifampicin. The traditional means of testing drug resistant microbe can be determined in a time of 3 to 6 months, during which the patient swallows handfuls of antibiotics who does not help him but strengthen the risk of microbe resistance.

“The new equipment reduces the late diagnosis of multidrug resistant tuberculosis from three months to less than one week, thus breaking the cycle of disease transmission in the community and preventing premature death of patients, while waiting for a diagnosis. Romanian Angel Appeal Foundation will still pay all the support to the National Programme for Prevention, Surveillance and Control of Tuberculosis, (including through this project) in the procurement of equipment and supplies for the laboratories, for rapid diagnosis of MDR TB, and the purchase of medicines for the correct, complete and quality treatment, motivated by the fact that this effort will undoubtedly translate into saved lives.” – Dr. Silvia Asandi, General Manager of the RAA Foundation.

Another series of eight rapid testing equipment (GeneXpert) and specific test kits will be purchased and installed in eight laboratories included in the project.

In parallel, since March, has been held the enrollment of patients with MDR/XDR-TB to receive complete, continuous, and quality treatment. In late April, 68 patients were enrolled for treatment and other 400 cases were identified as eligible, after collecting and analyzing information received from the TB units in Bucharest and 26 counties.

Quality medicines to ensure full and continuous treatment are all purchased from Norwegian funds, to cover therapy to 1500 patients with resistant tuberculosis. Treatment with appropriate antibiotics, administered as early as possible and took entirely until healing, is mandatory for microbes not to gain increased resistance and TB not to become difficult or impossible to cure. That’s even more important considering the fact that a MDR TB patient that is not treated or under correct treatment (it has not been diagnosed or has been diagnosed late or not treated with proper medication) is contagious and risks to afflict others (family, colleagues, friends) and spreads a resistant bacilli.

Without proper treatment, the cure rate of resistant and extremely resistant tuberculosis is quite low (between 20-50%), therefore rapid diagnosis and complete treatment with appropriate anti-TB drugs are crucial for the patient’s chance at life.

The project “Improving the health status of the population in Romania, by increasing tuberculosis control” is based on the measures included in the National Tuberculosis Control Strategy 2013 – 2017, developed from the recommendations of WHO and ECDC (European Centre for Disease Prevention and Control) and its general objective is to strengthen TB control in Romania, focusing on multidrug resistant tuberculosis and extremely resistant (MDR-TB / XDR) and the poor and vulnerable groups.

 

Contact:
Costinela Caraene, PR Coordinator
Tel: 0721.151.187
e-mail: costinela.caraene@raa.ro

Eight laboratories in Romania began in April the rapid testing of the multidrug-resistant TB .
All counties were assigned for sending samples.

This month has started the MDR TB rapid testing in two TB reference laboratories (Bucharest and Cluj) and in the TB laboratories in Bacau, Brasov, Constanta, Craiova, Sibiu, Timisoara, all part of the National Programme for Prevention, Surveillance and Control of Tuberculosis. All counties were assigned and send samples to these laboratories, in order to ensure the patients access to modern diagnosis techniques. The eight laboratories perform rapid diagnosis of MDR/XDR TB, after being equipped with LPA and MGIT equipment and test kits, within the project.
So far, 707 people received rapid testing in the project.

A series of 8 GeneXpert rapid testing equipment and GeneXpert test kits will be purchased and installed in these eight laboratories. Equipment procurement contract was signed. As for the GeneXpert test kits procurement, the ANRMAP views were requested on the organization of a new procedure for selecting the supplier, because offers of companies participating in the project overcome the budget provided.


44 TB units in the country, being equipped for effective control of tuberculosis

A total of 44 protective hoods for laboratories and TB units, 10 LED microscopes, 3 Versatrek equipment and consumables, IT equipment, and 9 vehicles will be purchased to increase the capacity for effective control of TB in TB laboratories and units in Romania.
Currently, the technical specifications were developed for all these items and were made necessary papers and lists TB units which will be provided by the project.
Procurement procedures will be initiated in the next period. To buy microscopes, legal procedure for selecting the supplier will be released when the necessary funds become available. For Versatrek equipment, procurement procedure will be officially launched on specialized sites after the approval, by the Ministry of Health, of the unit investment list for 2015, and for the purchase of IT equipment and vehicles, the selection of suppliers will be launched after the receipt of the necessary funds and after the investments checklist approval by the Ministry of Health.

The laboratory personnel will also be trained in the TB infection control, and in April was completed the course curricula for training sessions.

The number of patients who receive continuous, complete and quality treatment through the project, increase.
Another 400 cases of MDR TB identified as eligible.

During April, 21 patients with MDR TB were enrolled in treatment, in addition to the 47 patients enrolled in March. Thus, at the end of April, 68 multidrug resistant TB patients were enrolled to receive continuous, complete and quality treatment.
The enrollment of patients in treatment is based on MDR TB commission decision, after examining the file of the patient and after the patient signs his consent sheet.
County coordinators have been identified for MDR TB (with responsibilities related to MDR TB case management, patient records transmission, including supervision by committee, supervision of medication orders for patients in the treatment of outpatient phase) and with their help was initiated the mapping of drug resistant tuberculosis patients who would be eligible to receive treatment through the project.
By the end of April, they collected information from Bucharest and 26 counties. The rest of the counties will transmit data until mid-May. After analyzing the database, experts have identified over 400 MDR TB patients potentially eligible to receive treatment in the project.


DOT and incentives for TB patients treated outpatients. 50 poor communities identified for providing support to prevent illness and increase treatment adherence

By the end of April, we collected information on 1,377 patients from Bucharest and 26 counties, diagnosed with resistant tuberculosis or with sensitive tuberculosis but who are at increased risk of mortality, treatment failure or abandonment, in order to centralize eligible cases to receive directly observed treatment (DOT) and support to increase adherence to treatment. The process continues and data are expected from all counties.
Meanwhile, the finalized the criteria for inclusion of patients in the project, and criteria for prioritizing cases. A patient is eligible to be enrolled, if he/she meets the following conditions: a. he/she is diagnosed with TB resistance (RR, MDR-TB, XDR-TB) or TB sensitive but has an increased risk of mortality, treatment failure or abandonment; b. he/she takes his drugs following the doctor’s recommendations; c. he/she takes anti-TB treatment as outpatient OR, he/she is at least at his/her second hospitalization by the time of his/her inclusion in the project.
The priority criteria to be enrolled in the project:
a. TB patients with MDR / XDR
b. patients with other chemoresistance
c. patients ‘chronic’ with retreatment
d. patients with retreatment due to abandonment or failure.

At the end of April, following the centralization of records of consent, a total of 218 patients will receive social support, which will be awarded in May.

Also in April, it was completed the identification of 50 poor communities where there will be provided integrated interventions to prevent transmission of tuberculosis and to increase treatment adherence. There were also identified the community workers who will work effectively with patients, after receiving training.


The World Health Organization (WHO) will provide technical assistance to the National Programme for Prevention, Surveillance and Control of Tuberculosis

In April, representatives of the Ministry of Health (operator of program), the Pulmonology Institute “Marius Nasta” (project promoter) and of the World Health Organization attended a working meeting with President of ANRMAP in order to identify legal solution, according to the GEO 34/2006, for directly contracting the WHO services of technical assistance for TB control. The project’s team will send an address to ANRMAP, specifying the relevant aspects for meeting the criteria for exception to GEO 34/2006, pursuant to Articles 14.a and c.


The training of healthcare workers starts. They will be able to provide information about tuberculosis to TB patients, vulnerable groups and the general population

The first tranche of funding was disbursed to the Norwegian partner LHL International Tuberculosis Foundation which coordinates the action to inform patients, vulnerable populations and the general public about tuberculosis. First, healthcare workers will be trained in order to be able to implement information campaigns. Their first training session will take place in the second half of May.


Coming soon, the project brochure

The activities to inform policy makers and the general public about the activities in the project continue. No 3 of the bilingual Newsletter was sent at the end of April and the project’s presentation brochure could be printed in May.

For receiving information about the control of TB in Romania, please subscribe to our Newsletter by entering your e-mail in dedicated field clicking the Subscribe button (in the right column).


Expenditure for the period 1 to 30 April 2015 are shown in the table below:

BUDGET LINE

Value of expenses

in M9

Human Resources

374,388.00

Travel Costs for the staff and volunteers

0.00

Consumables

1,889,186.92

Investigation Costs (under the upper limit established for each project)

0.00

Other costs related to the services supply to the beneficiaries

498,061.47

Project Communication and Promotion

0.00

Bilateral activities

0.00

Other subcontracted activities

330.90

Indirect Costs

11,598.44

Unexpected Costs

0.00

Total

2,773,565.73

 

 

 

We asked Dr. Daniela Homorodean how the national laboratory network looks now, what are the challenges of the specialists’ activity and what will the new equipment bring. This is what she said for us:

“For the current situation in Romania, doing a microscopic exam for tuberculosis control is not enough. For a better surveillance of the endemic we need, for each patient, microscopic exam, as well as culture and drug sensitivity test. In the sputum we examine routinely for the pulmonary tuberculosis there must be 10,000 bacilli per millilitre of product, for us to be able to see one bacillus at the microscopic exam.

When bacilli appear, which we see coloured through special colorations at the microscopic exam, the lesions of the lung are quite advanced. Then, using other methods, we increase the chances to highlight the bacilli in early stages of the diseases, when the lesions are not so advanced. Thus, the chances of curing with less scars and lesions on the lung increase, because tuberculosis is a treatable infectious disease which can be cured. But, if the lesions are too extended, then it is cured through fibrosation, a scar-like tissue is formed. It is a fibrous tissue which doesn’t allow the lung to normally expand and relax. The bigger the lesions, the more extended is the fibrosis.

There are about 100 laboratories that diagnose and have as scope of work the bacteriologic diagnosis of tuberculosis, spread in all the counties. In each county there is a lab doing tuberculosis diagnosis. Starting with 2003, we began to run visits in the laboratory network and we selected some enthusiasts among the colleagues working in TB labs, good professionals, willing to participate in the control and guidance visits in the laboratories in the country. Immediately after we had the opportunity to accredit the laboratories according to the EU quality standards. Initially, 38 laboratories out of 50 proposed got accreditation, because only those met the criteria. Through the methods we’ve had so far, we got results after two or two and a half months, when we found out whether the germs eliminated by the patients were sensitive to the antimicrobials or resistant.

In eight regional laboratories and two national ones – Bucharest and Cluj – we have now the possibility to run genetic testing, in 24 or 48 ours, for the presence of the microbe in the sputum and the resistance of that microbe to the most powerful drugs – Isoniazid and Rifampicine. The resistance to these two drugs defines the multidrug-resistant TB. If the microbe is resistant to these two drugs, other substances, more powerful and more expensive, some of them with toxic effects, should be added to the treatment. It is best if, from the beginning, the patients accept the treatment so that the microbes not gain resistance, follow exactly the treatment without missing one single doze and not give up some of the drugs, because they think that three or four are too many. It is a big mistake, because from a treatable and curable disease, the person can develop a form difficult to treat and maybe impossible to cure. Then, such a non-compliant patient could make other people ill, and they will have since the beginning drug resistant tuberculosis. To find out about these cases as soon as possible, the genetic tests received through the Norwegian funds are essential. These are equipments which function with specific reagents and need special fit-up design. The reagents are procured also from Norwegian funds.

Through these projects, 9 cars shall be procured for the transport of products from the periphery to the diagnostic centres, so that by collecting the products we shall have rapid and quality diagnosis. It is not at all cost-efficient to keep a laboratory that only tests 3 sputa per day.

In 1999 we had other funding from the World Bank and five laboratories received the same equipment for doing culture on liquid media. Through that project, the laboratories had reagents for one year. Then, due to lack of funding, some of the laboratories stopped their activity, some others continued, but at a very low level, for serious forms.

We have to make sure that all the laboratories provide comparable diagnosis. The patients are quite mobile during the months or years of illness and go from one hospital to another. Or maybe they travel, get sick and get another set of tests. The results are compared with the previous bacteriological tests and they should be comparable, so that the monitoring can be correct and real and we can use the same scale and system of expressing results. I really like to believe that we had good results in the laboratories. It’s not a pleasure to work daily with sputum – not the best sight – but if you can deal with it and consider it a necessity, then you understand the relief of establishing a positive diagnosis and telling the patient that they have tuberculosis, not cancer. It is indeed, a relief.”

Simona (37) is an economist in Bucharest and she was told she has MDR-TB almost two months ago. She has been in hospital ever since.

“I got TB from my brother-in-law, who is also hospitalized here.

It started with pneumonia – I started coughing, so I went to the doctor and he told me I had an untreated pneumonia. I underwent treatment with antibiotics; then the doctor did an X-ray and told me it looked better. I told him I had come for my pneumonia but also because I had a case of TB in the family. He said that if I had had TB, the antibiotic he had given me would not have had any effect.

The next time I came for an X-ray, the doctor told me he had the impression there was something else there, that it was no longer pneumonia. One week later, I got a call from the clinic and I was told to come urgently. The DST had come out with tuberculosis.

I have never been ill, neither have I taken drugs, underwent treatment or been admitted to any hospital. I had a good immune system, I eat healthy, I do not smoke and I do not drink coffee or alcohol. In 37 years, I have never been in hospital. If I felt ill, I would let the system fight on its own, and I would not take drugs.

Sunday before I left for the hospital, I cried a lot. Everything was new for me: from an active and healthy person, suddenly I had to be hospitalized.

At first, it was difficult in the hospital; I would wake up in a state of panic in the morning, when I had to take the medication. I felt fear and rejection inside. It is not easy because there are days when I simply cannot walk and I can barely articulate words. There are days and days…

I have to be strong and take it easy. You need to encourage yourself and learn to do things on your own. Everything starts with you.”

 

“I am not as strong as before, yet I drag myself along”

Ioana (45) comes from Mediaș and she suffers from extensive resistant tuberculosis. In March, she was hospitalized along with her daughter (14) also a MDR suspect. Should the suspicion be confirmed, her daughter will become one of the patients included in the project “Improving the Health Status of the Romanian Population through the Increase of the TB Control Capacity”.

“Last year I spent 9 months here. I am unfit to work, but I am glad I can cook, clean and help my daughter. We can barely make ends meet from my pension and her survivor’s benefit. We limit ourselves to what we have. We live in a studio where we have what we need. We are poor, but we can afford to pay for the heating and to buy food.

When I was 19 years old, I suffered from drug-sensitive tuberculosis. I have had two relapses since then and, in the third, the doctors diagnosed me with MDR. When I was little, I had once a sore throat so severe that I could no longer speak, and when I enrolled at the university, they did some X-rays. ‘No file, no university – the hospital’, they told me. After me and my husband divorced, I had a relapse, my immune system was weakened, and I keep telling myself it was nerve-related.

My eldest boy’s father, who also has TB, died in 1995 of TB and we still do not know what kind of TB it was. One of my husband’s brothers also died of TB. His mother and sister had no idea what drugs he was taking. When the doctor learned that I had MDR-TB, he told me that I got it from my husband.

He hardly followed his treatment.

I had a 12 hours a day job and I neglected my diet. I worked as a clothes manufacturer. I finished post-secondary school, I was in the Technical Quality Control for a while and then I was somewhat of a shift manager. I have not worked since 2007. Until 2008, I was on first-line therapy. It was in 2008 that the doctors in Mediaş considered testing me to see whether I was resistant to drugs. The tests showed I was resistant to two drugs and they kept me there for another 4 months. When my child got sick, I did not leave him in Mediaş, instead I took him to Sibiu and later to Bucharest.

His condition is improving.

I am feeling so-so now. I am not as strong as before, yet I drag myself along. My daughter is in the 8th grade and she wants to go to the military high school so she had to do some tests. There was something wrong with her lungs. The doctors still do not know what it is, but they suspect she got it from us.

We were not alarmed because she was feeling well and ate well. She is a good student and she wants to study mathematics and computer science, however she can no longer enrol at the military high school. We have been in hospital for almost a month now, but we are to go home soon.

When I was ill and I could not manage on my own, my mother and my daughter would help me, and we would help each other. We are used to living on our own, just the two of us.

 

« Previous PageNext Page »